Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5467]
News [12724]
Articles [180]
Editorials [5]
Conferences [249]
elearning [17]
Music therapy has positive effects on young cancer patients’ coping skills, social integration, and family environment
Music therapy has positive effects on young cancer patients’ coping skills, social integration, and family...
Personalised tumour vaccines improve interleukin-2 treated metastatic melanoma
Personalised tumour vaccines improve interleukin-2 treated metastatic melanoma
Claims of a universal cure for cancer 'misleading'
Claims of a universal cure for cancer 'misleading'
Genomic study identifies subgroups of HER2 breast cancer with varying sensitivities to anti-HER2 treatment
Genomic study identifies subgroups of HER2 breast cancer with varying sensitivities to anti-HER2 treatment
Most women undergoing conservative surgery for vulvar cancer maintain healthy body image and sex life
Most women undergoing conservative surgery for vulvar cancer maintain healthy body image and sex life
Breakthrough announced in treatment of patient with rare type of leukaemia
Breakthrough announced in treatment of patient with rare type of leukaemia
ASCO GI: Ras status predicts response to second-line treatment with panitumumab for metastatic colorectal cancer
ASCO GI: Ras status predicts response to second-line treatment with panitumumab for metastatic colorectal cancer
ASCO GI: Pre-operative oral capecitabine chemotherapy is equivalent to infusional 5-FU for rectal cancer
ASCO GI: Pre-operative oral capecitabine chemotherapy is equivalent to infusional 5-FU for rectal cancer
ASCO GI: New, rationally-based chemotherapy combination appears highly effective in patients with treatment-resistant neuroendocrine tumours
ASCO GI: New, rationally-based chemotherapy combination appears highly effective in patients with treatment...
ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality of life for patients with metastatic gastric cancer
ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation